Quantcast

Latest Clinical trial Stories

2014-09-08 08:30:55

LONDON, September 8, 2014 /PRNewswire/ -- Richmond Pharmacology Ltd (Richmond) is proud to announce that it has received approval for 10% of all Phase I clinical trials conducted in the UK, expanding its market share significantly in 2013. (Logo: http://photos.prnewswire.com/prnh/20140820/700275-a ) (Photo: http://photos.prnewswire.com/prnh/20140820/700273-a ) (Photo: http://photos.prnewswire.com/prnh/20140820/700273-b ) Dr Jorg Taubel, CEO of...

2014-09-08 08:30:20

- Data show improvements in hemodynamic parameters and exercise capacity SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported top-line results from a Phase 2 study of AIR001 (sodium nitrite) inhalation solution for the treatment of pulmonary arterial hypertension (PAH). Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals, Inc. earlier this year. In the primary efficacy analysis...

2014-09-08 08:29:26

--Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection-- NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive...

2014-09-08 08:29:23

Immune Pharmaceuticals Recently Uplisted to NASDAQ Capital Market CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Sept. 8, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ and NASDAQ OMX First North Premier, Stockholm: "IMNP"; "Immune" or "the Company"), today announced it will be featured as a presenting company at the 16(th) Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10,...

2014-09-05 23:06:32

Alicare Medical Management (AMM), a national leader in care management solutions that promotes cost savings and client satisfaction, announces the publication of an issue brief titled “The Impact of the Affordable Care Act on Clinical Trials.” White Plains, NY (PRWEB) September 05, 2014 Alicare Medical Management (AMM), a national leader in care management solutions that promotes cost savings and client satisfaction, announces the publication of an issue brief titled “The Impact of...

2014-09-05 23:06:04

Select Clinical Trials, a premier public service for all individuals interested in medical research, launched a new website that catalogues leading clinical trials conducted by doctors and healthcare professionals that the public can participate in. Cincinnati, OH (PRWEB) September 05, 2014 Select Clinical Trials (SCT), a nationwide service that provides clinical trial opportunities for the public, announced today they have launched their premier website. The company designed their...

2014-09-04 16:27:20

WHITEHOUSE STATION, N.J., Sept. 4, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) at a dose of 2 mg/kg every three weeks for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor. This indication is approved under accelerated...

2014-09-04 08:31:11

PLYMOUTH MEETING, Pa., Sept. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will transfer its U.S. stock exchange listing from the NYSE MKT to the NASDAQ Global Select Market on September 15, 2014. The company will retain its current ticker symbol, "INO." Dr. J. Joseph Kim, President and CEO, said, "The majority of our peers are listed on NASDAQ, the world's largest...

2014-09-04 08:29:33

BOSTON, Sept. 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Dr. Tracy Tsuetaki as Senior Vice President for Peri/Post-Approval Services and PAREXEL Consulting. He will oversee the strategy and operational management for both businesses. He will also serve on PAREXEL's Business Review Committee, the Company's senior-most leadership team, and assist in developing and...

2014-09-03 12:31:52

Nearly 20 New Multi-Year iMedNet Agreements Signed Year-to-Date MINNETONKA, Minn., Sept. 3, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that sponsors and CROs around the world are increasingly selecting iMedNet(TM) EDC as their eClinical solution of choice. New iMedNet customers include multiple Top 10 Clinical Research Organizations (CROs) as well as Top 10 pharmaceutical/animal...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'